tiprankstipranks
Adial Pharmaceuticals Announces CMO’s Departure and Leadership Changes
Company Announcements

Adial Pharmaceuticals Announces CMO’s Departure and Leadership Changes

Don't Miss our Black Friday Offers:

Adial Pharmaceuticals Inc (ADIL) has issued an update.

Adial Pharmaceuticals, Inc. has announced the termination of its consulting agreement with Dr. Bankole A. Johnson, which will result in his departure from the role of Chief Medical Officer effective May 17, 2024. The agreement, in place since March 2019 and amended twice in 2022, marks a significant change in the company’s leadership structure.

For detailed information about ADIL stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAdial Pharmaceuticals Advances AD04 with Promising Study Results
TheFlyAdial Pharmaceuticals announces topline results from AD04-103 PK study
TheFlyAdial Pharmaceuticals initiated with a Buy at Rodman & Renshaw
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App